Although Bcl-2 promotes cell survival by two fully validated mechanisms, only the mechanism involving binding and inhibition of pro-apoptotic proteins is targeted for cancer treatment by the small-molecule BH3-mimetic ABT-263 (Figure 8). This evidence concerns the gene BCL2 and cancer.